Nanotechnology Now |
Home > News > Old Company Press Releases > FirstStage Capital News
Firststage Capital Secures $6M Venture Capital Financing For Oxonica
Funding boosts Nanotechnology spinout
FirstStage Capital, the corporate finance house that specialises in
securing funding for early stage technology companies, has advised on a $6
million venture capital fund raising for Oxonica, global pioneers in
Nanotechnology and a spinout from the University of Oxford.
This is the first round of institutional investment and includes funds
committed by VCF Partners, BASF Venture Capital GmbH, NextGen Partners
LLC, Northern Venture Managers and Generics Asset Management Ltd.
Oxonica specialises in the creation of Nanoparticles. Using patented
techniques to assemble them, the company produces materials that are only
few atoms in size and have innovative chemical and physical properties.
Oxonica is already conducting field trials for products that address real
life problems in a number of areas such as catalysis, medical diagnostics,
healthcare and personal care (e.g. cosmetics).
"This investment is testament to the strength of Oxonica's world-class
technology, and importantly, its ability to generate real volume product
sales in the short term." says Kevin Matthews, CEO of Oxonica. "FirstStage
Capital have put together an excellent syndicate of venture capitalists
and corporate venturers with the expertise to help grow our business".
Hazel Moore, chairman of FirstStage Capital comments "Only the very best
technology companies are receiving investment in the current environment.
We are impressed by the strength of Oxonica's management team and are
confident that Oxonica has every chance of becoming a world leading UK
technology company".
About FirstStage Capital
FirstStage Capital is a corporate finance house that specialises in
raising venture capital for early stage technology companies
(www.firststagecapital.com).
For further comment or information contact Hazel Moore, Chairman or Sonal
Shah, Analyst, FirstStage Capital on 020 7613 4333,
sonal.shah@firststagecapital.com.
About Oxonica
Oxonica is an exciting young company working in the field of applied
Nanotechnology, science on the atomic scale, heralded by the USA's
National Science and Technology Council as becoming "as socially
transforming as the development of running water, electricity,
antibiotics, and microelectronics". A spin out from the University of
Oxford in 1999, Oxonica is built upon intellectual property developed over
seven years by Professor Peter Dobson and Dr Gareth Wakefield. Oxonica
has gone on to add further intellectual property to its portfolio, and
currently has 15 filed patents. Oxonica's proprietary techniques enable
it to rapidly create prototype Nanoparticles, typically in the range of 5
to a few hundred nanometres*, and evaluate the differences in their
properties to identify Nanoparticles with appropriate functionality to
solve a given problem.
For further information, please visit www.oxonica.com Oxonica is based at
7 Begbroke Science Park, Sandy Lane, Yarnton, Kidlington, Oxon OX5 1PF,
United Kingdom. Tel +44 (0) 1865 847 200. E-mail info@oxonica.com
If you have a comment, please
us.
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
Subscribe to the Forbes/Wolfe Nanotech Report & Get 2 Free Reports
Nanotechnology Now Featured Books
| © Copyright 1999-2012 7thWave, Inc. All Rights Reserved | PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE |